Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M. Wright, Michael J. LaRiviere, Jonathan Baron, Chibueze Zimuzo Uche, Ying Xiao, W. Tristram Arscott, Emily J. Anstadt, Andrew R. Barsky, David S. Miller, Meredith I LaRose, Daniel J. Landsburg, Jakub Svoboda, Sunita D. Nasta, James N. Gerson, Stefan K. Barta, Elise A. Chong, Stephen J. Schuster, Ima Paydar, Amit Maity, John P. Plastaras
Topics & Concepts
Chimeric antigen receptorRadiation therapyLymphomaRefractory (planetary science)MedicineCancer researchAntigenOncologyImmunologyInternal medicineImmunotherapyBiologyImmune systemAstrobiologyCAR-T cell therapy researchLymphoma Diagnosis and TreatmentImmunotherapy and Immune Responses